Pulse Entdecken nav.journalClub Debatten Trends Forschende

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

Mizuho Fukunaga‐Kalabis | Synapse

MF

Mizuho Fukunaga‐Kalabis

Melanoma and MAPK Pathways

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Research focus

Melanoma and MAPK Pathways

Impact

81 pubs · 5,026 cites · h-index 24

Affiliations

Work Experience

Merck & Co., Inc., Rahway, NJ, USA (United States)

2022 - 2025

The Wistar Institute

2006 - 2022

Wista (Germany)

2016 - 2016

Publications